טוען...
Impact of Muscarinic M(3) Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study
BACKGROUND: M(3) muscarinic receptor antagonism has been associated with glucose intolerance and disturbance of insulin secretion. OBJECTIVE: Our objective was to examine the risk of type 2 diabetes mellitus (T2DM) in patients using antidepressants with and without M(3) muscarinic receptor antagonis...
שמור ב:
| הוצא לאור ב: | CNS Drugs |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5488147/ https://ncbi.nlm.nih.gov/pubmed/28527131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-017-0436-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|